Key result
Captopril increased renin secretion in conscious rats via sympathetic activation and interruption of the ANG II short feedback loop, without prostaglandin involvement.
Why the study?
Does captopril increase renin release via prostaglandins, beta-adrenergic activation, or angiotensin II feedback in conscious rats?
Does captopril increase renin release via prostaglandins, beta-adrenergic activation, or angiotensin II feedback in conscious rats?
Captopril-induced renin release in rats is mediated by sympathetic activation and interruption of ANG II feedback, rather than prostaglandin pathways.
Answers are grounded in this paper and cite their sources.
Cautions against extrapolating rat mechanisms to patients; leaves open confirmation of sympathetic and ANG II pathways in human ACE inhibitor responses.
The increase in plasma renin activity after angiotensin I-converting enzyme inhibition by Captopril (SQ 14225) is well documented. In a study of the mechanism of Captopril-induced renin release, conscious rats were treated with Captopril (100 mg/kg per day) in their drinking water. Plasma renin activity (PRA) rose sixfold to a plateau after 5 days. At the end of 5 days of treatment with Captopril, rats carrying Alzet osmotic minipumps which infused angiotensin II (ANG II) at 200 ng/kg per min intraperitoneally had a slightly elevated PRA, as opposed to a greatly suppressed one, in ANG II-infused controls (P < 0.05). Urinary prostaglandin ((PG)E2) daily excretion was unchanged by dietary Captopril. Indomethacin (5 mg/kg) injected subcutaneously significantly reduced plasma PGE2 after 90 min, whereas PRA in Captopril-treated rats was unchanged after indomethacin injection. Results were similar in ANG II-infused Captopril-treated rats. Propranolol (10 mg/kg) injected intraperitoneally significantly reduced PRA 45 min later, but the PRA of ANG II-infused rats was not lower after propranolol injection under Captopril treatment than in similar rats not infused with ANG II. Indomethacin did not potentiate the effects of propranolol or propranolol plus ANG II on PRA of Captopril-treated rats. In conclusion, Captopril increased renin secretion by β-adrenergically mediated activation of the sympathetic nervous system and by interruption of the short feeback loop of ANG II. PGs did not appear to be involved. Other factors may be operating, since propranolol plus ANG II did not normalize PRA.
No takes yet. Share an insight, caveat, or question.
Schiffrin et al. (1981) studied this question. Captopril vs. Controls was evaluated on Plasma renin activity (PRA) (p=<0.05). Captopril increased renin secretion in conscious rats via sympathetic activation and interruption of the ANG II short feedback loop, without prostaglandin involvement.
Synapse has enriched 10 related papers. Consider them for comparative context: